Dr. Steve Burnell is CEO of Minderoo Foundation’s Collaborate Against Cancer Initiative, leads Minderoo’s COVID-19 Response and is establishing a research program in marine genomics. Steve has a dual passion for working at the intersections of technology with healthcare and our environment, being particularly focused on how to improve the way data is used to improve cancer care and marine conservation. He joined Minderoo Foundation from the Roche Group, the world’s largest biotech, where he has run global businesses in diagnostics and more recently established a new informatics and real-world data business in oncology.
Steve’s 30+ years experience in research and business spans academia, strategy consulting, healthcare and personalized medicine. He holds a B.Sc. with honors in Biology and a Ph.D. in Population Biology from the University of Sydney, Australia. Steve and his family relocated to Perth, Australia from the San Francisco Bay area in January 2020.
